Vatex is developing a hybrid medical device-IT system to combat the abuse and trafficking of prescription drugs- a healthcare epidemic.
Vatex was formed to address the problem of prescription medication abuse. Vatex is developing Divert-X to monitor adherence to regimens for Controlled Substances. Patient compliance or behaviors consistent with abuse and trafficking will be established from real-time data of access to individual drug doses. Prescription drug misuse imposes a >$150 billion economic burden on US insurers- our customers. We will save lives and reduce costs.